Fundraising Fox

Charles Dunn

Investor

Principal at SV Health Investors

London

Writes $100K – $5M checks · typically $1.5M

About

Charles Dunn joined SV Health Investors in 2018 as a Principal on the biotech team, where he helps form and fund companies developing new medicines across early creation to later-stage public and private opportunities. Before SV he qualified as an ACA after three years at Deloitte serving Life Sciences clients, and has an academic background in human genetics and molecular biology from UCL.

LinkedIn ↗

Invests in

Biotech

Experience

  1. SV Health InvestorsPrincipalcurrent2023 — present
  2. SV Health InvestorsVice President2022 — 2023
  3. SV Health InvestorsSenior Investment Associate2021 — 2022
  4. SV Health InvestorsInvestment Associate2019 — 2021London, United Kingdom
  5. SV Health InvestorsInvestment Analyst2018 — 2019London, United Kingdom
  6. Draig TherapeuticsMember Board of Directors & Founding Investorcurrent2024 — present
  7. Imbria PharmaceuticalsMember Board of Directorscurrent2023 — present
  8. Imbria PharmaceuticalsBoard Observer2020 — 2023
  9. Mestag TherapeuticsMember Board of Directorscurrent2023 — present
  10. Mestag TherapeuticsBoard Observer & Founding Team2020 — 2023
  11. PulmocideBoard Observercurrent2020 — present
  12. Autifony TherapeuticsBoard Observercurrent2019 — present
  13. Enara BioBoard Observer2020 — 2024
  14. ZarodexBoard Observer2019 — 2021
  15. Deloitte UKAssistant Manager2016 — 2017Cambridge, United Kingdom
  16. Deloitte UKSenior Associate (Entrepreneurial Business)2015 — 2016
  17. Deloitte UKAssociate (Entrepreneurial Business)2014 — 2015

Education

  1. UCLMSci, Human/Medical Genetics2009 — 2014
  2. ICAEWACA2014 — 2017
  3. Hills Road Sixth Form College2006 — 2008

Same school

Also attended UCL272

André DuboisInvestor at Index VenturesFrédérique DameInvestor at GV (Google Ventures)Jonas VetterleInvestor at Moonfire VenturesMarie FerriInvestor at DaphniElena PantaziPartner & Head of Platform at NorthzoneGiovanni MariggiInvestor at Medicxi

+ 266 more

Also attended ICAEW110

Abdul GueforManaging Director at Intel CapitalJames BraithwaiteFinancial Controller at NorthzoneJackson HeddyCFO at NorthzoneSian CathrallPartner (joining next fund) at 4Di CapitalStephen ChandlerManaging Partner at Notion CapitalJinil ShahFinance Director at Notion Capital

+ 104 more

Shared employers

Also worked at SV Health Investors25

Victoria TaylorInvestor at MedicxiAmy SlizofskiInvestor at TRANSFORMATION CAPITALAlexander Sinclair-Wilson执行董事 at Qiming Venture PartnersPaul LaVioletteManaging Partner at SV Health InvestorsGreg MaddenManaging Partner at SV Health InvestorsEugene HillChairman at SV Health Investors

+ 19 more

Also worked at Draig Therapeutics3

Laetitia SchwabPrincipal at SR One Capital ManagementMegInvestor at Sanofi VenturesJodie MorrisonVenture Partner at Atlas Venture

Also worked at Mestag Therapeutics3

Issi RozenInvestor at GV (Google Ventures)Diana BernsteinDirector at Northpond VenturesFiona MacLaughlinVice President, Venture Investments at Johnson & Johnson Innovation – JJDC

Also worked at Enara Bio2

Rana Al-HallaqPartner at Pfizer Venture InvestmentsDan MarksPrincipal at RA Capital

Deals · 1

Draig TherapeuticsLed round

via SV Health Investors

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at SV Health Investors

A.J. Rossi
Partner at SV Health Investors
Aaron Sandoski
MCF Partner at SV Health Investors
Alex Badamchi-Zadeh
Vice President at SV Health Investors
Andrew Cappetta
Senior Associate at SV Health Investors
Brent Faduski
CFO, CCO and Partner at SV Health Investors
Christian Jung
Partner at SV Health Investors
Darren Black
Partner at SV Health Investors
Dirk Landgraf
Principal at SV Health Investors

Network6

Alex Badamchi-Zadeh
Vice President at SV Health Investors
Christian Jung
Partner at SV Health Investors
Darren Black
Partner at SV Health Investors
Dirk Landgraf
Principal at SV Health Investors
Emily Gaudiano
Associate at SV Health Investors
Eugene Hill
Chairman at SV Health Investors

Investors connected to Charles in public investor directories — a warm-intro map.